Fluconazole in hypercalciuric patients with increased 1,25(OH)2D levels: the prospective, randomized, placebo-controlled, double-blind FLUCOLITH trial

Aurélia Bertholet‐Thomas(Lyon 1 Université), Justine Bacchetta(Université Claude Bernard Lyon 1), Arnaud Molin(Centre Hospitalier Universitaire de Caen Normandie), Sacha Flammier(Hospices Civils de Lyon), Inesse Boussaha(Inserm), Valérie Laudy(Inserm), Laurence Dubourg(Lyon 1 Université), Marietou Ndiaye(Inserm), C. Dhelens(Hôpital Edouard Herriot), Aurélie Portefaix(Hospices Civils de Lyon), Myrtille Le Bouar(Inserm), Sandrine Lemoine(Inserm), Fabien Subtil(Lyon 1 Université)
Trials
June 16, 2022
Cited by 7


Related Papers